Search

Your search keyword '"Stewart, Hj"' showing total 10 results
Start Over "Stewart, Hj" Database Gale General OneFile Publisher bmj publishing group ltd.
10 results on '"Stewart, Hj"'

1. Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance. (Original Article)

Author

Bakker, M.A. den, Weeszenberg, A. van, Kanter, A.Y. de, Beverdam, F.H., Pritchard, C., Kwast, Th H. van der, and Menke-Pluymers, M.

Subjects
Lymph nodes -- Influence -- Physiological aspects -- Statistics, Metastasis -- Statistics -- Evaluation -- Physiological aspects, Lymphatic metastasis -- Statistics -- Evaluation -- Physiological aspects, Breast cancer -- Physiological aspects -- Statistics, Health, Influence, Statistics, Evaluation, Physiological aspects
Abstract

Aims: It has been suggested that patients with T1-2 breast tumours and sentinel node (SLN) micrometastases, defined as foci of tumour cells smaller than 2 mm, may be spared completion [...]

Published
2002

2. Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial

Author

McDonald, Carolyn C., Alexander, Freda E., Whyte, Bruce W., Forrest, A. Patrick, and Stewart, Helen J.

Subjects
Tamoxifen -- Complications and side effects, Heart diseases -- Risk factors -- Complications and side effects, Peripheral vascular diseases -- Risk factors -- Complications and side effects, Blood clot -- Risk factors -- Complications and side effects, Blood clotting -- Risk factors, Thrombosis -- Risk factors -- Complications and side effects, Chemotherapy, Cancer -- Chemotherapy, Breast cancer -- Risk factors -- Complications and side effects, Health, Complications and side effects, Risk factors
Abstract

Abstract Objective - To determine any cardiac or vascular morbidity associated with long term treatment with tamoxifen given after mastectomy for primary breast cancer. Design - Cohort study using linkage [...]

Published
1995

3. Management of early breast cancer

Author

Rubens, R.D.

Subjects
Breast cancer -- Care and treatment, Health, Care and treatment
Abstract

Breast cancer is Britain's most common malignancy in women, estimated to affect one in 12 of the female population. About 80% of women present with apparently localised disease which is [...]

Published
1992

4. Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial

Author

McDonald, C.C. and Stewart, H.J.

Subjects
Tamoxifen -- Cases -- Complications and side effects, Heart attack -- Cases -- Prevention -- Complications and side effects, Chemotherapy -- Cases, Cancer -- Chemotherapy, Breast cancer -- Prevention -- Cases -- Complications and side effects, Health, Company legal issue, Prevention, Complications and side effects, Cases
Abstract

Introduction Tamoxifen is a non-steroidal antioestrogen and is considered to be the front line endocrine treatment for breast cancer. It is widely used in postmenopausal women both as treatment for [...]

Published
1991

5. Adjuvant tamoxifen: how long before we know how long?

Author

Rea, Daniel, Poole, Christopher, and Gray, Richard

Subjects
Tamoxifen -- Health aspects -- Dosage and administration, Cancer -- Adjuvant treatment, Drugs -- Dosage and administration, Health, Dosage and administration, Health aspects
Abstract

Despite recent advances, we still need more information from large clinical trials to define the optimum duration of tamoxifen treatment after surgery for breast cancer. Tamoxifen is the most widely [...]

Published
1998

6. A randomised controlled trial of feedback to general practitioners of their prophylactic aspirin prescribing

Author

McCartney, Peter, Macdowall, Wendy, and Thorogood, Margaret

Subjects
Aspirin -- Usage, Coronary heart disease -- Drug therapy, Drugs -- Prescribing, Health, Drug therapy, Usage
Abstract

Although low dose aspirin reduces risk in patients with heart disease, many such patients do not receive daily prophylactic aspirin.[1] We report a trial of feedback of general practitioners' data [...]

Published
1997

8. How safe is tamoxifen?

Author

Jordan, V. Craig

Subjects
Tamoxifen -- Complications and side effects, Postmenopausal women -- Diseases -- Drug therapy, Breast cancer -- Drug therapy -- Complications and side effects, Health, Drug therapy, Diseases, Complications and side effects
Abstract

Only large randomised controlled trials can decide Tamoxifen has emerged as the main endocrine treatment for all stages of breast cancer.[1] Adjuvant tamoxifen produces a survival advantage, irrespective of oestrogen [...]

Published
1993

9. Long term effects of tamoxifen on blood lipid values in breast cancer

Author

Dewar, J.A., Horobin, J.M., Preece, P.E., Tavedale, R., Tunstall-Pedoe, H., and Wood, R.A.B.

Subjects
Tamoxifen -- Evaluation, Blood cholesterol, Cancer -- Adjuvant treatment, Blood lipids, Breast cancer, Health, Evaluation
Abstract

Tamoxifen is now established as adjuvant therapy in patients with operable breast cancer.[1] As large numbers of women take it for many years its other metabolic effects are important.[2] A [...]

Published
1992

Catalog

Books, media, physical & digital resources
See catalog results